Business Description
LungLife AI Inc
NAICS : 621512
SIC : 2835
ISIN : USU5500L1045
Description
LungLife AI Inc is focused on a developing clinical diagnostic solutions for lung cancer. The Company generates revenue from People's Republic of China and also has its presence in the United States of America.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.18 | |||||
| Equity-to-Asset | 0.83 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -11.39 | |||||
| Beneish M-Score | -2.13 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -45 | |||||
| 3-Year EBITDA Growth Rate | -12.8 | |||||
| 3-Year EPS without NRI Growth Rate | -8.9 | |||||
| 3-Year FCF Growth Rate | -23.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 3.66 | |||||
| 9-Day RSI | 10.13 | |||||
| 14-Day RSI | 15.99 | |||||
| 6-1 Month Momentum % | -62.02 | |||||
| 12-1 Month Momentum % | -41.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.28 | |||||
| Quick Ratio | 2.28 | |||||
| Cash Ratio | 1.96 | |||||
| Days Sales Outstanding | 1527.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 3.49 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -12697.22 | |||||
| Net Margin % | -11894.44 | |||||
| FCF Margin % | -11166.67 | |||||
| ROE % | -50.74 | |||||
| ROA % | -43.62 | |||||
| ROIC % | -77.72 | |||||
| ROC (Joel Greenblatt) % | -1132.74 | |||||
| ROCE % | -49.05 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 95 | |||||
| PB Ratio | 0.78 | |||||
| Price-to-Tangible-Book | 2.55 | |||||
| EV-to-EBIT | -0.91 | |||||
| EV-to-Forward-EBIT | -0.97 | |||||
| EV-to-EBITDA | -0.96 | |||||
| EV-to-Forward-EBITDA | -1.02 | |||||
| EV-to-Revenue | 107.5 | |||||
| EV-to-Forward-Revenue | 0.88 | |||||
| EV-to-FCF | -0.96 | |||||
| Price-to-Net-Current-Asset-Value | 4.08 | |||||
| Price-to-Net-Cash | 5.1 | |||||
| Earnings Yield (Greenblatt) % | -109.89 | |||||
| FCF Yield % | -69.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
LungLife AI Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.042 | ||
| EPS (TTM) (€) | -0.196 | ||
| Beta | 0 | ||
| Volatility % | 202.57 | ||
| 14-Day RSI | 15.99 | ||
| 14-Day ATR (€) | 0.029834 | ||
| 20-Day SMA (€) | 0.2692 | ||
| 12-1 Month Momentum % | -41.22 | ||
| 52-Week Range (€) | 0.184 - 1.56 | ||
| Shares Outstanding (Mil) | 30.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
LungLife AI Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
LungLife AI Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
LungLife AI Inc Frequently Asked Questions
What is LungLife AI Inc(FRA:9H4)'s stock price today?
The current price of FRA:9H4 is €0.20. The 52 week high of FRA:9H4 is €1.56 and 52 week low is €0.18.
When is next earnings date of LungLife AI Inc(FRA:9H4)?
The next earnings date of LungLife AI Inc(FRA:9H4) is 2024-08-08 Est..
Does LungLife AI Inc(FRA:9H4) pay dividends? If so, how much?
LungLife AI Inc(FRA:9H4) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers